Article Text
Abstract
The World Medical Association’s revised Declaration of Helsinki endorses the view that all trial participants in every country are entitled to the worldwide best standard of care. In this paper the authors show that this requirement has been rejected by every national and international committee that has examined this issue. They argue that the consensus view now holds that it is ethically permissible, in some circumstances, to provide research participants less than the worldwide best care. Finally, the authors show that there is also consensus regarding the broad conditions under which this is acceptable.
- international research ethics
- research ethics
- CIOMS, Council for International Organizations of Medical Sciences
- NBAC, National Bioethics Advisory Commission
- UNAIDS, United Nations Programme on HIV/AIDS
- WMA, World Medical Association
Statistics from Altmetric.com
Footnotes
-
The opinions expressed are the authors’ own. They do not reflect any position or policy of the National Institutes of Health, Public Health Service, or Department of Health and Human Services.
Read the full text or download the PDF:
Other content recommended for you
- The standard of care debate: against the myth of an “international consensus opinion”
- Ethical concerns regarding guidelines for the conduct of clinical research on children
- Cultural considerations for informed consent in paediatric research in low/middle-income countries: a scoping review
- Addressing ethical challenges in HIV prevention research with people who inject drugs
- Algorithm for the support of non-related (serious) adverse events in an Ebola vaccine trial in the Democratic Republic of the Congo
- Regulation of biomedical research in Africa
- The quality of informed consent: mapping the landscape. A review of empirical data from developing and developed countries
- International requirements for consent in biobank research: qualitative review of research guidelines
- Post-trial access to study medication: a Brazilian e-survey with major stakeholders in clinical research
- Is it ethical to deny genetic research participants individualised results?